Bastiaan Sallevelt

52 CHAPTER 2.1 References 1. Davies EA, O’Mahony MS. Adverse drug reactions in special populations - The elderly. Br J Clin Pharmacol 2015. 2. Mangoni AA, Jackson SHD. Age-related changes in pharmacokinetics and pharmacodynamics: Basic principles and practical applications. Br J Clin Pharmacol 2004. 3. Zazzara MB, Palmer K, Vetrano DL, Carfì A, Graziano O. Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med 2021;12:463–73. https://doi. org/10.1007/s41999-021-00481-9. 4. Oscanoa TJ, Lizaraso F, Carvajal A. Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol 2017. 5. Alhawassi TM, Krass I, Bajorek B, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging 2014. 6. Roulet L, Ballereau F, Hardouin JB, Chiffoleau A, Potel G, Asseray N. Adverse drug event nonrecognition in emergency departments: An exploratory study on factors related to patients and drugs. J Emerg Med 2014;46:857–64. jemermed.2013.11.124. 7. Nickel CH, Ruedinger JM, Messmer AS, Maile S, Peng A, Bodmer M, et al. Drug - related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med 2013;21:1. 8. Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, Purssell RA. Do Emergency Physicians Attribute Drug-Related Emergency Department Visits to MedicationRelated Problems? Ann Emerg Med 2010;55:493-502.e4. annemergmed.2009.10.008. 9. Nair NP, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR. Hospitalization in older patients due to adverse drug reactions - The need for a prediction tool. Clin Interv Aging 2016;11:497–505. 10. Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, Somers A, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR risk score. Arch Intern Med 2010;170:1142–8. 11. Griffin F, Resar R. IHI Global Trigger Tool for measuring adverse events. IHI Innov Ser White Pap 2007:1–44. 12. Carnevali L, Krug B, Amant F, Van Pee D, G??rard V, de B??thune X, et al. Performance of the Adverse Drug Event Trigger Tool and the Global Trigger Tool for Identifying Adverse Drug Events: Experience in a Belgian Hospital. Ann Pharmacother 2013;47:1414–9. 13. Toscano Guzmán MD, Galván Banqueri M, Otero MJ, Sánchez Fidalgo S, Font Noguera I, Pérez Guerrero MC. Validating a Trigger Tool for Detecting Adverse Drug Events in Elderly Patients With Multimorbidity (TRIGGER-CHRON). J Patient Saf 2018;Publish Ah:1–7. 14. Otero MJ, Toscano Guzmán MD, Galván-Banqueri M, Martinez-Sotelo J, Santos-Rubio MD. Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity. Eur J Hosp Pharm 2020:1–6.